MDGL vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

MDGL

53.3
AI Score
VS
BBIO Wins

BBIO

72.8
AI Score

Investment Advisor Scores

MDGL

53score
Recommendation
HOLD

BBIO

73score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MDGL BBIO Winner
Forward P/E 78.125 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 71.2% 120.4% BBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 53.3/100 72.8/100 BBIO
Profit Margin -25.3% -97.0% MDGL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

MDGL 1M: -7.2% · 3M: -5.4% BBIO 1M: -12.6% · 3M: -13.3%

Current Technical Phase

MDGL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $499.71

BBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 36

RSI (14): 36.5 · Price: $66.91

Fundamentals Snapshot

Metric MDGL BBIO
Market Cap — —
Forward P/E 51.9 2433.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.7% 1.2%
Gross Margin 0.9% 0.9%
Operating Margin -0.2% -0.4%
EPS -13.98 -3.56
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.